These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 25524722)
21. Invalidating human gene patenting: the U.S. Supreme Court rules in Association for Molecular Pathology v. Myriad Genetics. Kalyvas J; Little AS World Neurosurg; 2013 Dec; 80(6):680-1. PubMed ID: 24134909 [No Abstract] [Full Text] [Related]
22. Mayo, Myriad, America Invents Act and BPCIA: how has the United States biopharmaceutical market been affected? Finston SK; Davey NS; Davé E; Ravichandran V; Davey SR; Davé RS Pharm Pat Anal; 2016 May; 5(3):159-67. PubMed ID: 27087460 [TBL] [Abstract][Full Text] [Related]
23. Canada's Supreme Court abolishes 'promise of the patent'. Norman J; Gloor A Pharm Pat Anal; 2018 Jan; 7(1):1-5. PubMed ID: 29227204 [TBL] [Abstract][Full Text] [Related]
24. Patent law: live, human-made microorganisms are patentable subject matter under 35 U.S.C. Sect. 101--Diamond v. Chakrabarty. Namei FT Univ Cincinnati Law Rev; 1980; 49(4):902-13. PubMed ID: 11650489 [No Abstract] [Full Text] [Related]
26. Take off your genes and let the doctor have a look: why the Mayo and Myriad decisions have invalidated method claims for genetic diagnostic testing. Bergin C Am Univ Law Rev; 2013; 63(1):173-217. PubMed ID: 25335200 [TBL] [Abstract][Full Text] [Related]
27. Biotechnology patent law developments in Great Britain and the United States: analysis of a hypothetical patent claim for a synthesized virus. Auerbach BC Boston College Int Comp Law Rev; 1983; 6(2):563-90. PubMed ID: 11649615 [No Abstract] [Full Text] [Related]
28. Stem cell patents after the america invents act. Sherkow JS; Scott CT Cell Stem Cell; 2015 May; 16(5):461-4. PubMed ID: 25957901 [TBL] [Abstract][Full Text] [Related]
30. Patent law. Law and science collide over human gene patents. Cook-Deegan R Science; 2012 Nov; 338(6108):745-7. PubMed ID: 23139317 [No Abstract] [Full Text] [Related]
31. The Federal Circuit's decision in Myriad: isolated DNA molecules are patentable subject matter. Ogden SR Am Univ Law Rev; 2011; 61(2):443-56. PubMed ID: 25335196 [No Abstract] [Full Text] [Related]
32. Intellectual property. Supreme Court rules out patents on 'natural' genes. Marshall E Science; 2013 Jun; 340(6139):1387-8. PubMed ID: 23788772 [No Abstract] [Full Text] [Related]
33. More patent troubles about genes. Nature; 1994 Dec; 372(6506):485. PubMed ID: 7990908 [TBL] [Abstract][Full Text] [Related]
34. Patents and laboratory medicine: what is required to turn an unpatentable natural phenomenon or law of nature into a patentable invention? Powlick JT Clin Chem; 2012 Aug; 58(8):1205-7. PubMed ID: 22504119 [No Abstract] [Full Text] [Related]
35. Patents--patentable subject matter--living man-made organisms held to be patentable subject matter under 35 U.S.C. Section 101. Day MT Marquette Law Rev; 1980; 63(4):711-30. PubMed ID: 11662894 [No Abstract] [Full Text] [Related]
36. The gap between law and moral order: an examination of the legitimacy of the Supreme Court abortion decisions. Wardle LD Brigh Young Univ Law Rev; 1980; 1980(4):811-35. PubMed ID: 11655721 [No Abstract] [Full Text] [Related]
38. [Patentability of DNA sequences: the debate remains open]. Martín Uranga A Rev Derecho Genoma Hum; 2013; (39):83-95. PubMed ID: 24868958 [TBL] [Abstract][Full Text] [Related]
39. Are living organisms proper subject matter for a patent? United States Supreme Court to decide question of first impression in Parker v. Bergy. Slade RJ; Van den Broder JM West State Univ Law Rev; 1979; 7(1):125-131. PubMed ID: 11662797 [No Abstract] [Full Text] [Related]
40. The war against junk science: the use of expert panels in complex medical-legal scientific litigation. Price JM; Rosenberg ES Biomaterials; 1998 Aug; 19(16):1425-32. PubMed ID: 9794513 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]